Intellia Therapeutics NTLA beats Q4 estimates as revenue climbs 169 percent annually shares rise 277 percent Marcus MMI Stock Why Brand Strength Momentum Building 20260418 VMO Invesco Municipal Opportunity Trust reports 575 percent year over year Q1 2026 revenue decline and mild 010 percent share uptick Rein Therapeutics RNTX Holds Steady at 111 as Key Support and Resistance Levels Define Range Trumps Taiwan Comments Stir Geopolitical Uncertainty for Markets MFA Financial Q1 2026 Earnings EPS Slightly Misses Estimates Amid Stable Operations Wealthsimple Expands Retail Investor Access to Select Canadian and US IPOs